KALA BIO, Inc. (KALA)
NASDAQ·Healthcare·Biotechnology
$0.17
+9.56%
Mkt Cap $3.68M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$18.25
Range $1.50 – $35.00
Implied Upside
+10585.0%
Consensus $18.25 vs current $0.17
NASDAQ·Healthcare·Biotechnology
$0.17
+9.56%
Mkt Cap $3.68M
No recent rating data.
Price Target (5 analysts)
$18.25
Range $1.50 – $35.00
+10585.0%
Consensus $18.25 vs current $0.17